Reversal-Specific Learning Impairments after a Binge Regimen of Methamphetamine in Rats: Possible Involvement of Striatal Dopamine

Neuropsychopharmacology

Volumn 35, Issue 2, 2010, Pages 505-514

  Izquierdo, Alicia ^a   Belcher, Annabelle M ^b   Scott, Lori ^a   Cazares, Victor A ^a   Chen, Jack ^a   O'Dell, Steven J ^b   Malvaez, Melissa ^b   Wu, Tiffany ^b   Marshall, John F ^b  

^a CALIFORNIA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Behavioral flexibility; Compulsivity; Inhibitory control; Psychostimulants; Reversal, attentional set shifting

Indexed keywords

3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; DOPAMINE TRANSPORTER; METHAMPHETAMINE; SEROTONIN TRANSPORTER;

ACCURACY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENTION; BRAIN FUNCTION; CONTROLLED STUDY; CORPUS STRIATUM; DISCRIMINATION LEARNING; LEARNING DISORDER; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECOGNITION; TASK PERFORMANCE; VISUAL DISCRIMINATION; WISCONSIN CARD SORTING TEST;

ANALYSIS OF VARIANCE; ANIMALS; ATTENTION; BODY TEMPERATURE; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; CORPUS STRIATUM; DISCRIMINATION (PSYCHOLOGY); DISEASE MODELS, ANIMAL; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; LEARNING DISORDERS; MALE; METHAMPHETAMINE; NEUROPSYCHOLOGICAL TESTS; PHOTIC STIMULATION; PROTEIN BINDING; RADIOPHARMACEUTICALS; RATS; RATS, LONG-EVANS; RECOGNITION (PSYCHOLOGY); REVERSAL LEARNING;

EID: 72449194703     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/npp.2009.155     Document Type: Article

References (71)

1. Bechara A, Dolan S, Denburg N, Hindes A, Anderson SW, Nathan PE (2001). Decision-making deficits, linked to a dysfunctional ventromedial prefrontal cortex, revealed in alcohol and stimulant abusers. Neuropsychologia 39: 376-389.
2. Belcher AM, Feinstein EM, O'Dell SJ, Marshall JF (2008). Methamphetamine influences on recognition memory: comparison of escalating and single-day dosing regimens. Neuropsycho-pharmacology 33: 1453-1463.
3. Belcher AM, O'Dell SJ, Marshall JF (2005). Impaired object recognition memory following methamphetamine, but not p-chloroamphetamine-or d-amphetamine-induced neurotoxicity. Neuropsychopharmacology 30: 2026-2034.
4. Belcher AM, O'Dell SJ, Marshall JF (2006). A sensitizing regimen of methamphetamine causes impairments in a novelty preference task of object recognition. Behav Brain Res 170: 167-172.
5. Belcher AM, O'Dell SJ, Marshall JF (2009). Long-term changes in dopamine-stimulated gene expression after single-day metham-phetamine exposure. Synapse 63: 403-412.
6. Berendse HW, Galis-De Graaf Y, Groenewegen HJ (1992). Topographical organization and relationship with ventral striatal compartments of prefrontal corticostriatal projections in the rat. J Comp Neurol 316: 314-347.
7. Birrell JM, Brown VJ (2000). Medial frontal cortex mediates perceptual attentional set shifting in the rat. J Neurosci 20: 4320-4324.
8. Bisagno V, Ferguson D, Luine VN (2002). Short toxic metham-phetamine schedule impairs object recognition task in male rats. Brain Res 940: 95-101.
9. Block AE, Dhanji H, Thompson-Tardif SF, Floresco SB (2007). Thalamic-prefrontal cortical-ventral striatal circuitry mediates dissociable components of strategy set shifting. Cereb Cortex 17: 1625-1636.
10. Boja JW, Mitchell WM, Patel A, Kopajtic TA, Carroll FI, Lewin AH et al. (1992). High-affinity binding of [125I]RTI-55 to dopamine and serotonin transporters in rat brain. Synapse 12: 27-36.
11. Chung A, Lyoo IK, Kim SJ, Hwang J, Bae SC, Sung YH et al. (2007). Decreased frontal white-matter integrity in abstinent metham-phetamine abusers. Int J Neuropsychopharmacol 10: 765-775.
12. Clarke HF, Robbins TW, Roberts AC (2008). Lesions of the medial striatum in monkeys produce perseverative impairments during reversal learning similar to those produced by lesions of the orbitofrontal cortex. J Neurosci 28: 10972-10982.
13. Clatworthy PL, Lewis SJG, Brichard L, Hong YT, Izquierdo D, Clark L et al. (2009). Dopamine release in dissociable striatal subregions predicts the different effects of oral methylphenidate on reversal learning and spatial working memory. J Neurosci 29: 4690-4696.
14. Commins DL, Seiden LS (1986). alpha-Methyltyrosine blocks methylamphetamine-induced degeneration in the rat somato-sensory cortex. Brain Res 365: 15-20.
15. Cools R, Frank MJ, Gibbs SE, Miyakawa A, Jagust W, D'Esposito M (2009). Striatal dopamine predicts outcome-specific reversal learning and its sensitivity to dopaminergic drug administration. J Neurosci 29: 1538-1543.
16. Daberkow DP, Riedy MD, Kesner RP, Keefe KA (2008). Effect of methamphetamine neurotoxicity on learning-induced Arc mRNA expression in identified striatal efferent neurons. Neurotox Res 14: 307-315.
17. Dalley JW, Laane K, Theobald DE, Pena Y, Bruce CC, Huszar AC et al. (2007). Enduring deficits in sustained visual attention during withdrawal of intravenous methylenedioxymethamphe-tamine self-administration in rats: results from a comparative study with d-amphetamine and methamphetamine. Neuropsy-chopharmacology 32: 1195-1206.
18. Dalley JW, Mar AC, Economidou D, Robbins TW (2008). Neurobehavioral mechanisms of impulsivity: fronto-striatal systems and functional neurochemistry. Pharmacol Biochem Behav 90: 250-260.
19. Eisch AJ, Gaffney M, Weihmuller FB, O'Dell SJ, Marshall JF (1992). Striatal subregions are differentially vulnerable to the neurotoxic effects of methamphetamine. Brain Res 598: 321-326.
20. Eisch AJ, Marshall JF (1998). Methamphetamine neurotoxicity: dissociation of striatal dopamine terminal damage from parietal cortical cell body injury. Synapse 30: 433-445.
21. Everitt BJ, Belin D, Economidou D, Pelloux Y, Dalley JW, Robbins TW (2008). Review. Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction. Philos Trans R Soc Lond B Biol Sci 363: 3125-3135.
22. Everitt BJ, Robbins TW (2005). Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci 8: 1481-1489.
23. Everitt BJ, Wolf ME (2002). Psychomotor stimulant addiction: a neural systems perspective. J Neurosci 22: 3312-3320.
24. Featherstone RE, Rizos Z, Kapur S, Fletcher PJ (2008). A sensitizing regimen of amphetamine that disrupts attentional set-shifting does not disrupt working or long-term memory. Behav Brain Res 189: 170-179.
25. Fletcher PJ, Tenn CC, Rizos Z, Lovic V, Kapur S (2005). Sensitization to amphetamine, but not PCP, impairs attentional set shifting: reversal by a D1 receptor agonist injected into the medial prefrontal cortex. Psychopharmacol (Berl) 183: 190-200.
26. Gibb JW, Stone DM, Stahl DC, Hanson GR (1987). The effects of amphetamine-like designer drugs on monoaminergic systems in rat brain. NIDA Res Monogr 76: 316-321.
27. Haluk DM, Floresco SB (2009). Ventral striatal dopamine modulation of different forms of behavioral flexibility. Neurop-sychopharmacology 34: 2041-2052.
28. Han DH, Yoon SJ, Sung YH, Lee YS, Kee BS, Lyoo IK et al. (2008). A preliminary study: novelty seeking, frontal executive function, and dopamine receptor (D2) TaqI A gene polymorphism in patients with methamphetamine dependence. Compr Psychiatry 49: 387-392.
29. He J, Yang Y, Yu Y, Li X, Li XM (2006). The effects of chronic administration of quetiapine on the methamphetamine-induced recognition memory impairment and dopaminergic terminal deficit in rats. Behav Brain Res 172: 39-45.
30. Herring NR, Schaefer TL, Gudelsky GA, Vorhees CV, Williams MT (2008a). Effect of +-methamphetamine on path integration learning, novel object recognition, and neurotoxicity in rats. Psychopharmacology (Berl) 199: 637-650.
31. Herring NR, Schaefer TL, Tang PH, Skelton MR, Lucot JP, Gudelsky GA et al. (2008b). Comparison of time-dependent effects of (+)-methamphetamine or forced swim on mono-amines, corticosterone, glucose, creatine, and creatinine in rats. BMC Neurosci 9: 49.
32. Hollerman JR, Tremblay L, Schultz W (2000). Involvement of basal ganglia and orbitofrontal cortex in goal-directed behavior. Prog Brain Res 126: 193-215. (Pubitemid 35461290)
33. Holmes A, Wellman CL (2008). Stress-induced prefrontal reorganization and executive dysfunction in rodents. Neurosci Biobehav Rev 33: 773-783.
34. Izquierdo A, Wellman CL, Holmes A (2006a). Brief uncontrollable stress causes dendritic retraction in infralimbic cortex and resistance to fear extinction in mice. J Neurosci 26: 5733-5738.
35. Izquierdo A, Wiedholz LM, Millstein RA, Yang RJ, Bussey TJ, Saksida LM et al. (2006b). Genetic and dopaminergic modulation of reversal learning in a touchscreen-based operant procedure for mice. Behav Brain Res 171: 181-188.
36. Jones B, Mishkin M (1972). Limbic lesions and the problem of stimulus-reinforcement associations. Exp Neurol 36: 362-377.
37. Kalechstein AD, Newton TF, Green M (2003). Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence. J Neuropsychiatry Clin Neurosci 15: 215-220.
38. Kim SJ, Lyoo IK, Hwang J, Sung YH, Lee HY, Lee DS et al. (2005). Frontal glucose hypometabolism in abstinent methamphetamine users. Neuropsychopharmacology 30: 1383-1391. (Pubitemid 40848092)
39. Kolb B, Gorny G, Li Y, Samaha AN, Robinson TE (2003). Amphetamine or cocaine limits the ability of later experience to promote structural plasticity in the neocortex and nucleus accumbens. Proc Natl Acad Sci USA 100: 10523-10528.
40. Man MS, Clarke HF, Roberts AC (2008). The role of the orbitofrontal cortex and medial striatum in the regulation of prepotent responses to food rewards. Cereb Cortex 19: 899-906.
41. Marshall JF, Belcher AM, Feinstein EM, O'Dell SJ (2007). Methamphetamine-induced neural and cognitive changes in rodents. Addiction 102(Suppl 1): 61-69.
42. McAlonan K, Brown VJ (2003). Orbital prefrontal cortex mediates reversal learning and not attentional set shifting in the rat. Behav Brain Res 146: 97-103.
43. McCann UD, Kuwabara H, Kumar A, Palermo M, Abbey R, Brasic J et al. (2008). Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users. Synapse 62: 91-100.
44. Monchi O, Ko JH, Strafella AP (2006). Striatal dopamine release during performance of executive functions: A [(11)C] raclopride PET study. Neuroimage 33: 907-912.
45. Nagai T, Takuma K, Dohniwa M, Ibi D, Mizoguchi H, Kamei H et al. (2007). Repeated methamphetamine treatment impairs spatial working memory in rats: reversal by clozapine but not haloperidol. Psychopharmacology (Berl) 194: 21-32.
46. Nordahl TE, Salo R, Leamon M (2003). Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: a review. J Neuropsychiatry Clin Neurosci 15: 317-325.
47. O'Dell SJ, Weihmuller FB, Marshall JF (1993). Methamphetamine-induced dopamine overflow and injury to striatal dopamine terminals: attenuation by dopamine D1 or D2 antagonists. J Neurochem 60: 1792-1799.
48. O'Neill M, Brown VJ (2007). The effect of striatal dopamine depletion and the adenosine A2A antagonist KW-6002 on reversal learning in rats. Neurobiol Learn Mem 88: 75-81.
49. Ohmori T, Koyama T, Muraki A, Yamashita I (1993). Competitive and noncompetitive N-methyl-D-aspartate antagonists protect dopaminergic and serotonergic neurotoxicity produced by methamphetamine in various brain regions. J Neural Transm Gen Sect 92: 97-106.
50. Ornstein TJ, Iddon JL, Baldacchino AM, Sahakian BJ, London M, Everitt BJ et al. (2000). Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers. Neuropsychopharma-cology 23: 113-126.
51. Paxinos G, Watson C (2003). The Rat Brain Atlas in Stereotaxic Coordinates. 5th edn. Academic Press: Sydney.
52. Pontieri FE, Crane AM, Seiden LS, Kleven MS, Porrino LJ (1990). Metabolic mapping of the effects of intravenous methampheta-mine administration in freely moving rats. Psychopharmacology (Berl) 102: 175-182.
53. Ragozzino ME (2007). The contribution of the medial prefrontal cortex, orbitofrontal cortex, and dorsomedial striatum to behavioral flexibility. In: Schoenbaum G, Gottfied JA, Murray EA, Ramus SJ (eds). Linking Affect to Action: Critical Contributions of the Orbitofrontal Cortex. Blackwell Publishing: Boston. pp 355-375.
54. Ricaurte GA, Guillery RW, Seiden LS, Schuster CR, Moore RY (1982). Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain. Brain Res 235: 93-103.
55. Robbins TW (2005). Chemistry of the mind: neurochemical modulation of prefrontal cortical function. J Comp Neurol 493: 140-146.
56. Rogers RD, Everitt BJ, Baldacchino A, Blackshaw AJ, Swainson R, Wynne K et al. (1999). Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: evidence for monoami-nergic mechanisms. Neuropsychopharmacology 20: 322-339.
57. Schoenbaum G, Shaham Y (2008). The role of orbitofrontal cortex in drug addiction: a review of preclinical studies. Biol Psychiatry 63: 256-262.
58. Schoenbaum G, Saddoris MP, Ramus SJ, Shaham Y, Setlow B (2004). Cocaine-experienced rats exhibit learning deficits in a task sensitive to orbitofrontal cortex lesions. Eur J Neurosci 19: 1997-2002.
59. Schroder N, O'Dell SJ, Marshall JF (2003). Neurotoxic metham-phetamine regimen severely impairs recognition memory in rats. Synapse 49: 89-96.
60. Simon SL, Domier C, Carnell J, Brethen P, Rawson R, Ling W (2000). Cognitive impairment in individuals currently using methamphetamine. Am J Addict 9: 222-231.
61. Szumlinski KK, Haskew RE, Balogun MY, Maisonneuve IM, Glick SD (2001). Iboga compounds reverse the behavioural disinhibit-ing and corticosterone effects of acute methamphetamine: Implications for their antiaddictive properties. Pharmacol Biochem Behav 69: 485-491.
62. Takahashi Y, Roesch MR, Stalnaker TA, Schoenbaum G (2007). Cocaine exposure shifts the balance of associative encoding from ventral to dorsolateral striatum. Front Integr Neurosci 1: nihpa51247.
63. Tata DA, Yamamoto BK (2008). Chronic stress enhances methamphetamine- induced extracellular glutamate and excito-toxicity in the rat striatum. Synapse 62: 325-336.
64. Verdejo-Garcia A, Lawrence AJ, Clark L (2008). Impulsivity as a vulnerability marker for substance-use disorders: review of findings from high-risk research, problem gamblers and genetic association studies. Neurosci Biobehav Rev 32: 777-810.
65. Villemagne V, Yuan J, Wong DF, Dannals RF, Hatzidimitriou G, Mathews WB et al. (1998). Brain dopamine neurotoxicity in baboons treated with doses of methamphetamine comparable to those recreationally abused by humans: evidence from [11C]WIN-35,428 positron emission tomography studies and direct in vitro determinations. J Neurosci 18: 419-427.
66. Volkow ND, Chang L, Wang GJ, Fowler JS, Franceschi D, Sedler M et al. (2001a). Loss of dopamine transporters in methampheta-mine abusers recovers with protracted abstinence. J Neurosci 21: 9414-9418.
67. Volkow ND, Chang L, Wang GJ, Fowler JS, Ding YS, Sedler M et al. (2001b). Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry 158: 2015-2021.
68. Volkow ND, Chang L, Wang GJ, Fowler JS, Leonido-Yee M, Franceschi D et al. (2001c). Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry 158: 377-382.
69. Volkow ND, Fowler JS, Wang GJ, Swanson JM (2004). Dopamine in drug abuse and addiction: results from imaging studies and treatment implications. Mol Psychiatry 9: 557-569.
70. Volkow ND, Wang GJ, Telang F, Fowler JS, Logan J, Childress AR et al. (2006). Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. J Neurosci 26: 6583-6588.
71. Wilson JM, Kalasinsky KS, Levey AI, Bergeron C, Reiber G, Anthony RM et al. (1996). Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nat Med 2: 699-703.